At what enterprise value was CLAYENS GROUP acquired in 2019?

You can find the full valuation details of CLAYENS GROUP on mynth capital. By registering for free, you get access to complete and exact transaction details including enterprise value, revenue, and EBITDA. Additionally, our database shows that the Industry & Manufacturing industry currently tracks an average EBITDA multiple of 11.6x, providing a valuable benchmark for this transaction.

What was the EV/EBITDA of CLAYENS GROUP when it was acquired by SIPAREX?

The exact EV/EBITDA multiple for CLAYENS GROUP is available on mynth capital. For comparison, the Industry & Manufacturing sector currently shows an average EBITDA multiple of 11.6x. Join our community for free to access full valuation data and industry trends.

When was CLAYENS GROUP acquired by SIPAREX?

CLAYENS GROUP was acquired by SIPAREX in 2019.

What was the revenue of CLAYENS GROUP at the time of the deal?

The revenue of CLAYENS GROUP at the time of the deal is estimated to be in the range of 250M - 500M EUR. Register for free to access the full transaction report and exact valuation multiples.

What was the EBITDA of CLAYENS GROUP during the acquisition?

CLAYENS GROUP's EBITDA is estimated to be in the range of 25M - 50M EUR. Join our community for free to access complete and exact deal data.

What is Enterprise Value (EV)?

Enterprise Value (EV) is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. EV includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.

What is the EV/EBITDA multiple and why is it used?

The EV/EBITDA multiple is a financial ratio that compares a company's Enterprise Value (EV) to its Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA). It is widely used in M&A and valuation because it allows for comparisons between companies with different capital structures and provides a clear view of operational profitability.

How is the data for the CLAYENS GROUP acquisition sourced and is it reliable?

Mynth data is contributed by a professional community of M&A and Private Equity experts. Each transaction, including the CLAYENS GROUP deal, is systematically cross-verified by our team using private deal documents and official sources. You can also find the official press release for this transaction here: https://www.cfnews.net/L-actualite/LBO/Operations/Spin-off/Sintex-NP-retrouve-un-actionnariat-francais-306997

← DATABASE

Home Database Industry & ManufacturingCLAYENS GROUP

08/2019

SIPAREX takes majority stake in CLAYENS GROUP

FRANCE Chemicals & Materials / Material Transformation / Plastics REV 250M - 500M EUR

Context

The August 2019 transaction represents a complex corporate carve-out of Sintex NP from its listed Indian parent conglomerate, Sintex Industries, effectively repatriating the company’s ownership and governance into a domestic private sponsor-backed structure. This primary LBO is led by Siparex ETI 4 alongside its financial co-investors and features a substantial management equity reinvestment from a tier of twenty key corporate executives led by CEO Eric Pisani, ensuring complete operational alignment and leadership stability. The ownership transition is driven by the parent company’s strategic mandate to divest its high-performing European manufacturing division to alleviate liquidity pressures and optimize its domestic balance sheet. The capitalization of the transaction is supported by a comprehensive senior secured credit facility arranged and underwritten by a banking syndicate led by CACIB, which replaces the target's historical intra-group financing lines and establishes independent balance sheet flexibility.

CLAYENS GROUP, which reported an EBITDA margin of LOGIN in 2018, is valued in this transaction at an EV/EBITDA multiple of LOGIN, a level to compare with the average currently observed in the Industry & Manufacturing sector (11.6x).

Note that this data is based on contribution from our growing community, composed of M&A and Private Equity professionals, and has been verified by our team to ensure its accuracy.

-> Deep-dive in Industry & Manufacturing market trends

Target

Headquartered in Genas, France, Clayens Group is an outsourced contract manufacturer specializing in high-performance polymers, advanced composites, and precision metals. The company operates a manufacturing footprint of 25 facilities across Europe, North Africa, and North America, delivering high-specification components processed through thermoplastic and thermoset injection, metalloplastics, and precision metal machining. Revenue is generated from blue-chip multinational original equipment manufacturers and tier-1 suppliers in the aerospace, automotive, healthcare, electronics, and construction sectors. Client engagements are structured under multi-year procurement agreements tied directly to individual customer product lifecycles, with initial customer acquisition locked in during early-stage collaborative research and development and rigorous technical component qualification phases.

Ent. Value

Equity Value

Multiples

EV / Revenue

EV / EBITDA

EV / EBIT

Historical Financials (EUR)

Year

Rev

EBITDA

EBIT

2018

2017

Other operations with CLAYENS GROUP

List of similar M&A transactions (Date, Acquirer, Target, Country, Sector, Deal Context)
Date	Acquirer	Target	Country	Sector	Deal Context
07/2022	ONE EQUITY PARTNERS	CLAYENS GROUP	FRANCE	Chemicals & Materials	The acquisition of a majority stake in Clayens Group by One Equity Partners marks the exit of the previous majority shareholder, Siparex, which alongside existing co-investors and the incumbent management team led by CEO Eric Pisani, will reinvest as minority partners to maintain corporate continuity. Under Siparex’s stewardship since 2019, the group scaled its operations from €273 million to over €350 million in trailing twelve-month revenue, primarily driven by the execution of four strategic add-on acquisitions that expanded its geographic and technological footprint
09/2020	CLAYENS GROUP	PSB INDUSTRIES (HEALTHCARE & INDUSTRY)	FRANCE	Chemicals & Materials	This operation represents the first programmatic bolt-on acquisition executed by Clayens NP since its primary sponsor-backed buyout, designed to accelerate the platform’s diversification into highly resilient and high-margin healthcare manufacturing verticals. Negotiated on a proprietary bilateral basis due to long-standing industrial relationships and a previous site acquisition in 2017, the transaction allows the seller, PSB Industries, to complete its strategic pivot toward luxury and beauty packaging while divesting a non-core industrial asset

REFERENCES

Revenue range: 250M - 500M EUR

EBITDA range: 25M - 50M EUR

Note: This page provides detailed data on a private equity M&A transaction. Detailed and exact financial metrics for the acquisition of CLAYENS GROUP by SIPAREX are reserved for mynth community members. Register for free to unlock full data.

Authors: verified mynth contributor (mynth data is contributed by M&A / PE professionals and systematically cross-verified with private deal documents and official press releases).

Target: clayens group

Acquirer: siparex